Cero Therapeutics Holdings, INC. (CERO) — SEC Filings

Latest SEC filings for Cero Therapeutics Holdings, INC.. Recent 4 filing on Apr 21, 2026. AI-decoded analysis of earnings, risk factors, and insider trades

View Cero Therapeutics Holdings, INC. on SEC EDGAR

Overview

Cero Therapeutics Holdings, INC. (CERO) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 4 filed on Apr 21, 2026: On March 4, 2026, Eric Francois reported a change in beneficial ownership of securities for CERO THERAPEUTICS HOLDINGS, INC. The filing details transactions related to his holdings, but specific dollar amounts and the exact nature of the transactions are not provided in this excerpt.

Sentiment Summary

Across 2 filings, the sentiment breakdown is: 2 neutral. The dominant filing sentiment for Cero Therapeutics Holdings, INC. is neutral.

Filing Type Overview

Cero Therapeutics Holdings, INC. (CERO) has filed 1 3, 1 4 with the SEC between Apr 2026.

Recent Filings (2)

Frequently Asked Questions

What are the latest SEC filings for Cero Therapeutics Holdings, INC. (CERO)?

Cero Therapeutics Holdings, INC. has 2 recent SEC filings from Apr 2026, including 1 3, 1 4. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of CERO filings?

Across 2 filings, the sentiment breakdown is: 2 neutral. The dominant sentiment is neutral.

Where can I find Cero Therapeutics Holdings, INC. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Cero Therapeutics Holdings, INC. (CERO) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

View on Read The Filing